Kala Bio (KALA) Market Capitalization (2017 - 2026)

Kala Bio has disclosed Market Capitalization across 10 years of filings, most recently posting $26.4 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 98.34% year-over-year to $26.4 million; the TTM figure through Jun 2026 stood at $26.4 million (down 98.34% YoY), while the FY2025 annual figure was $226.5 million, down 82.8% from the prior year.
• Market Capitalization came in at $26.4 million for Q2 2026 at Kala Bio, down from $102.7 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $5.1 billion in Q1 2022 to a low of $26.4 million in Q2 2026.
• Average Market Capitalization over 5 years is $1.4 billion, with a median of $1.2 billion recorded in 2023.
• Year-over-year, Market Capitalization surged 68.44% in 2023 and slumped 98.34% in 2026.
• Over 5 years, Market Capitalization stood at $3.3 billion in 2022, then sank by 70.34% to $965.8 million in 2023, then surged by 36.39% to $1.3 billion in 2024, then plunged by 82.8% to $226.5 million in 2025, then sank by 88.32% to $26.4 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $26.4 million in Q2 2026, $102.7 million in Q1 2026, and $226.5 million in Q4 2025.